Antimicrobial resistance: Private providers are reversing progress by dispensing more drugs, top adviser warnsNovember 19, 2025
DNA & Genetics Korro Craters 81% on Data; Patient Death Sours Analysts on IntelliaBy adminNovember 18, 20250 Korro Bio (NASDAQ: KRRO) saw its stock reach its first of two all-time lows, cratering 81% Thursday after reporting disappointing…
